BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29294194)

  • 1. No association between the risk of breast cancer and systemic lupus erythematosus: evidence from a meta-analysis.
    Rezaieyazdi Z; Tabaei S; Ravanshad Y; Akhtari J; Mehrad-Majd H
    Clin Rheumatol; 2018 Jun; 37(6):1511-1519. PubMed ID: 29294194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid cancer in systemic lupus erythematosus: a meta analysis.
    Zhang M; Li XM; Wang GS; Qian L; Tao JH; Ma Y; Li XP
    Int J Clin Exp Pathol; 2014; 7(9):6270-3. PubMed ID: 25337279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis.
    Song L; Wang Y; Zhang J; Song N; Xu X; Lu Y
    Arthritis Res Ther; 2018 Dec; 20(1):270. PubMed ID: 30522515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of the epidemiological literature on the risk of urological cancers in systemic lupus erythematosus.
    Huang HB; Jiang SC; Han J; Cheng QS; Dong CB; Pan CM
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1067-73. PubMed ID: 24525705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.
    Ni J; Qiu LJ; Hu LF; Cen H; Zhang M; Wen PF; Wang XS; Pan HF; Ye DQ
    Lupus; 2014 Mar; 23(3):284-92. PubMed ID: 24429300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of systemic lupus erythematosus autoantibody diversity with breast cancer protection.
    Shah AA; Igusa T; Goldman D; Li J; Casciola-Rosen L; Rosen A; Petri M
    Arthritis Res Ther; 2021 Feb; 23(1):64. PubMed ID: 33632283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking and the risk of systemic lupus erythematosus: an updated systematic review and cumulative meta-analysis.
    Jiang F; Li S; Jia C
    Clin Rheumatol; 2015 Nov; 34(11):1885-92. PubMed ID: 26188616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between alcohol intake and the risk of systemic lupus erythematosus: A systematic review and meta-analysis.
    Wang J; Liu J; Pan L; Guo L; Liu C; Yang S
    Lupus; 2021 Apr; 30(5):725-733. PubMed ID: 33557684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and prevalence of tuberculosis in systemic lupus erythematosus patients: A systematic review and meta-analysis.
    Wu Q; Liu Y; Wang W; Zhang Y; Liu K; Chen SH; Chen B
    Front Immunol; 2022; 13():938406. PubMed ID: 35935948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus and risk of sexual dysfunction: A systematic review and Meta-Analysis.
    Jin Z; Yang C; Xiao C; Wang Z; Zhang S; Ren J
    Lupus; 2021 Feb; 30(2):238-247. PubMed ID: 33210559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Meta-Analysis of Cardiovascular Events in Systemic Lupus Erythematosus.
    Gu MM; Wang XP; Cheng QY; Zhao YL; Zhang TP; Li BZ; Ye DQ
    Immunol Invest; 2019 Jul; 48(5):505-520. PubMed ID: 30961407
    [No Abstract]   [Full Text] [Related]  

  • 12. Allergic rhinitis and risk of systemic lupus erythematosus: A systematic review and meta-analysis.
    Wongtrakul W; Charoenngam N; Ponvilawan B; Ungprasert P
    Int J Rheum Dis; 2020 Nov; 23(11):1460-1467. PubMed ID: 32749784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic lupus erythematosus increases risk of incident atrial fibrillation: A systematic review and meta-analysis.
    Chen Y; Fu L; Pu S; Xue Y
    Int J Rheum Dis; 2022 Oct; 25(10):1097-1106. PubMed ID: 35906745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccinations and risk of systemic lupus erythematosus and rheumatoid arthritis: A systematic review and meta-analysis.
    Wang B; Shao X; Wang D; Xu D; Zhang JA
    Autoimmun Rev; 2017 Jul; 16(7):756-765. PubMed ID: 28483543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis.
    Bernatsky S; Ramsey-Goldman R; Foulkes WD; Gordon C; Clarke AE
    Br J Cancer; 2011 Apr; 104(9):1478-81. PubMed ID: 21487409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimalarials may reduce cancer risk in patients with systemic lupus erythematosus: a systematic review and meta-analysis of prospective studies.
    Li XB; Cao NW; Chu XJ; Zhou HY; Wang H; Yu SJ; Ye DQ; Li BZ
    Ann Med; 2021 Dec; 53(1):1687-1695. PubMed ID: 34553648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle income countries: a systematic review and meta-analysis.
    Fatoye F; Gebrye T; Mbada C
    Rheumatol Int; 2022 Dec; 42(12):2097-2107. PubMed ID: 36006459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic lupus erythematous and malignancy risk: a meta-analysis.
    Cao L; Tong H; Xu G; Liu P; Meng H; Wang J; Zhao X; Tang Y; Jin J
    PLoS One; 2015; 10(4):e0122964. PubMed ID: 25885411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
    Zintzaras E; Voulgarelis M; Moutsopoulos HM
    Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of pancreatic cancer in patients with systemic lupus erythematosus: a meta-analysis.
    Seo MS; Yeo J; Hwang IC; Shim JY
    Clin Rheumatol; 2019 Nov; 38(11):3109-3116. PubMed ID: 31270697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.